Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Betahistine Market Growth 2022-2028

  • LP 4773718
  • 104 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Betahistine will have significant change from previous year. According to our (LP Information) latest study, the global Betahistine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Betahistine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Betahistine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Betahistine market, reaching US$ million by the year 2028. As for the Europe Betahistine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Betahistine players cover TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, and EA Pharma Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Betahistine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

8mg

25mg

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cerebral Thrombosis

Cerebral Embolism

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

TOWA PHARMACEUTICAL CO., LTD

Nichi-Iko Pharmaceutical

Takeda Pharmaceutical Company Limited

EA Pharma Co., Ltd.

Disphar International B.V.

HENNIG ARZNEIMITTEL GmbH & Co. KG

DOC Generici

Ciclum Farma Unipessoal

Mylan

Orion Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Betahistine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Betahistine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Betahistine by Country/Region, 2017, 2022 & 2028

2.2 Betahistine Segment by Type

2.2.1 8mg

2.2.2 25mg

2.2.3 Others

2.3 Betahistine Sales by Type

2.3.1 Global Betahistine Sales Market Share by Type (2017-2022)

2.3.2 Global Betahistine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Betahistine Sale Price by Type (2017-2022)

2.4 Betahistine Segment by Application

2.4.1 Cerebral Thrombosis

2.4.2 Cerebral Embolism

2.4.3 Others

2.5 Betahistine Sales by Application

2.5.1 Global Betahistine Sale Market Share by Application (2017-2022)

2.5.2 Global Betahistine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Betahistine Sale Price by Application (2017-2022)

3 Global Betahistine by Company

3.1 Global Betahistine Breakdown Data by Company

3.1.1 Global Betahistine Annual Sales by Company (2020-2022)

3.1.2 Global Betahistine Sales Market Share by Company (2020-2022)

3.2 Global Betahistine Annual Revenue by Company (2020-2022)

3.2.1 Global Betahistine Revenue by Company (2020-2022)

3.2.2 Global Betahistine Revenue Market Share by Company (2020-2022)

3.3 Global Betahistine Sale Price by Company

3.4 Key Manufacturers Betahistine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Betahistine Product Location Distribution

3.4.2 Players Betahistine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Betahistine by Geographic Region

4.1 World Historic Betahistine Market Size by Geographic Region (2017-2022)

4.1.1 Global Betahistine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Betahistine Annual Revenue by Geographic Region

4.2 World Historic Betahistine Market Size by Country/Region (2017-2022)

4.2.1 Global Betahistine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Betahistine Annual Revenue by Country/Region

4.3 Americas Betahistine Sales Growth

4.4 APAC Betahistine Sales Growth

4.5 Europe Betahistine Sales Growth

4.6 Middle East & Africa Betahistine Sales Growth

5 Americas

5.1 Americas Betahistine Sales by Country

5.1.1 Americas Betahistine Sales by Country (2017-2022)

5.1.2 Americas Betahistine Revenue by Country (2017-2022)

5.2 Americas Betahistine Sales by Type

5.3 Americas Betahistine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Betahistine Sales by Region

6.1.1 APAC Betahistine Sales by Region (2017-2022)

6.1.2 APAC Betahistine Revenue by Region (2017-2022)

6.2 APAC Betahistine Sales by Type

6.3 APAC Betahistine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Betahistine by Country

7.1.1 Europe Betahistine Sales by Country (2017-2022)

7.1.2 Europe Betahistine Revenue by Country (2017-2022)

7.2 Europe Betahistine Sales by Type

7.3 Europe Betahistine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Betahistine by Country

8.1.1 Middle East & Africa Betahistine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Betahistine Revenue by Country (2017-2022)

8.2 Middle East & Africa Betahistine Sales by Type

8.3 Middle East & Africa Betahistine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Betahistine

10.3 Manufacturing Process Analysis of Betahistine

10.4 Industry Chain Structure of Betahistine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Betahistine Distributors

11.3 Betahistine Customer

12 World Forecast Review for Betahistine by Geographic Region

12.1 Global Betahistine Market Size Forecast by Region

12.1.1 Global Betahistine Forecast by Region (2023-2028)

12.1.2 Global Betahistine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Betahistine Forecast by Type

12.7 Global Betahistine Forecast by Application

13 Key Players Analysis

13.1 TOWA PHARMACEUTICAL CO., LTD

13.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information

13.1.2 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered

13.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 TOWA PHARMACEUTICAL CO., LTD Main Business Overview

13.1.5 TOWA PHARMACEUTICAL CO., LTD Latest Developments

13.2 Nichi-Iko Pharmaceutical

13.2.1 Nichi-Iko Pharmaceutical Company Information

13.2.2 Nichi-Iko Pharmaceutical Betahistine Product Offered

13.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Nichi-Iko Pharmaceutical Main Business Overview

13.2.5 Nichi-Iko Pharmaceutical Latest Developments

13.3 Takeda Pharmaceutical Company Limited

13.3.1 Takeda Pharmaceutical Company Limited Company Information

13.3.2 Takeda Pharmaceutical Company Limited Betahistine Product Offered

13.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.3.5 Takeda Pharmaceutical Company Limited Latest Developments

13.4 EA Pharma Co., Ltd.

13.4.1 EA Pharma Co., Ltd. Company Information

13.4.2 EA Pharma Co., Ltd. Betahistine Product Offered

13.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 EA Pharma Co., Ltd. Main Business Overview

13.4.5 EA Pharma Co., Ltd. Latest Developments

13.5 Disphar International B.V.

13.5.1 Disphar International B.V. Company Information

13.5.2 Disphar International B.V. Betahistine Product Offered

13.5.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Disphar International B.V. Main Business Overview

13.5.5 Disphar International B.V. Latest Developments

13.6 HENNIG ARZNEIMITTEL GmbH & Co. KG

13.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information

13.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered

13.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Overview

13.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments

13.7 DOC Generici

13.7.1 DOC Generici Company Information

13.7.2 DOC Generici Betahistine Product Offered

13.7.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 DOC Generici Main Business Overview

13.7.5 DOC Generici Latest Developments

13.8 Ciclum Farma Unipessoal

13.8.1 Ciclum Farma Unipessoal Company Information

13.8.2 Ciclum Farma Unipessoal Betahistine Product Offered

13.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ciclum Farma Unipessoal Main Business Overview

13.8.5 Ciclum Farma Unipessoal Latest Developments

13.9 Mylan

13.9.1 Mylan Company Information

13.9.2 Mylan Betahistine Product Offered

13.9.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Mylan Main Business Overview

13.9.5 Mylan Latest Developments

13.10 Orion Corporation

13.10.1 Orion Corporation Company Information

13.10.2 Orion Corporation Betahistine Product Offered

13.10.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Orion Corporation Main Business Overview

13.10.5 Orion Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Betahistine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Betahistine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 8mg

Table 4. Major Players of 25mg

Table 5. Major Players of Others

Table 6. Global Betahistine Sales by Type (2017-2022) & (K Units)

Table 7. Global Betahistine Sales Market Share by Type (2017-2022)

Table 8. Global Betahistine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Betahistine Revenue Market Share by Type (2017-2022)

Table 10. Global Betahistine Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Betahistine Sales by Application (2017-2022) & (K Units)

Table 12. Global Betahistine Sales Market Share by Application (2017-2022)

Table 13. Global Betahistine Revenue by Application (2017-2022)

Table 14. Global Betahistine Revenue Market Share by Application (2017-2022)

Table 15. Global Betahistine Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Betahistine Sales by Company (2020-2022) & (K Units)

Table 17. Global Betahistine Sales Market Share by Company (2020-2022)

Table 18. Global Betahistine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Betahistine Revenue Market Share by Company (2020-2022)

Table 20. Global Betahistine Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Betahistine Producing Area Distribution and Sales Area

Table 22. Players Betahistine Products Offered

Table 23. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Betahistine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Betahistine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Betahistine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Betahistine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Betahistine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Betahistine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Betahistine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Betahistine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Betahistine Sales by Country (2017-2022) & (K Units)

Table 35. Americas Betahistine Sales Market Share by Country (2017-2022)

Table 36. Americas Betahistine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Betahistine Revenue Market Share by Country (2017-2022)

Table 38. Americas Betahistine Sales by Type (2017-2022) & (K Units)

Table 39. Americas Betahistine Sales Market Share by Type (2017-2022)

Table 40. Americas Betahistine Sales by Application (2017-2022) & (K Units)

Table 41. Americas Betahistine Sales Market Share by Application (2017-2022)

Table 42. APAC Betahistine Sales by Region (2017-2022) & (K Units)

Table 43. APAC Betahistine Sales Market Share by Region (2017-2022)

Table 44. APAC Betahistine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Betahistine Revenue Market Share by Region (2017-2022)

Table 46. APAC Betahistine Sales by Type (2017-2022) & (K Units)

Table 47. APAC Betahistine Sales Market Share by Type (2017-2022)

Table 48. APAC Betahistine Sales by Application (2017-2022) & (K Units)

Table 49. APAC Betahistine Sales Market Share by Application (2017-2022)

Table 50. Europe Betahistine Sales by Country (2017-2022) & (K Units)

Table 51. Europe Betahistine Sales Market Share by Country (2017-2022)

Table 52. Europe Betahistine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Betahistine Revenue Market Share by Country (2017-2022)

Table 54. Europe Betahistine Sales by Type (2017-2022) & (K Units)

Table 55. Europe Betahistine Sales Market Share by Type (2017-2022)

Table 56. Europe Betahistine Sales by Application (2017-2022) & (K Units)

Table 57. Europe Betahistine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Betahistine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Betahistine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Betahistine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Betahistine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Betahistine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Betahistine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Betahistine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Betahistine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Betahistine

Table 67. Key Market Challenges & Risks of Betahistine

Table 68. Key Industry Trends of Betahistine

Table 69. Betahistine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Betahistine Distributors List

Table 72. Betahistine Customer List

Table 73. Global Betahistine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Betahistine Sales Market Forecast by Region

Table 75. Global Betahistine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Betahistine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Betahistine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Betahistine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Betahistine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Betahistine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Betahistine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Betahistine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Betahistine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Betahistine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Betahistine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Betahistine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Betahistine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Betahistine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Betahistine Revenue Market Share Forecast by Application (2023-2028)

Table 93. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 94. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered

Table 95. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. TOWA PHARMACEUTICAL CO., LTD Main Business

Table 97. TOWA PHARMACEUTICAL CO., LTD Latest Developments

Table 98. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 99. Nichi-Iko Pharmaceutical Betahistine Product Offered

Table 100. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Nichi-Iko Pharmaceutical Main Business

Table 102. Nichi-Iko Pharmaceutical Latest Developments

Table 103. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 104. Takeda Pharmaceutical Company Limited Betahistine Product Offered

Table 105. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Takeda Pharmaceutical Company Limited Main Business

Table 107. Takeda Pharmaceutical Company Limited Latest Developments

Table 108. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 109. EA Pharma Co., Ltd. Betahistine Product Offered

Table 110. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. EA Pharma Co., Ltd. Main Business

Table 112. EA Pharma Co., Ltd. Latest Developments

Table 113. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 114. Disphar International B.V. Betahistine Product Offered

Table 115. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Disphar International B.V. Main Business

Table 117. Disphar International B.V. Latest Developments

Table 118. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 119. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered

Table 120. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business

Table 122. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments

Table 123. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 124. DOC Generici Betahistine Product Offered

Table 125. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. DOC Generici Main Business

Table 127. DOC Generici Latest Developments

Table 128. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 129. Ciclum Farma Unipessoal Betahistine Product Offered

Table 130. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Ciclum Farma Unipessoal Main Business

Table 132. Ciclum Farma Unipessoal Latest Developments

Table 133. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 134. Mylan Betahistine Product Offered

Table 135. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Mylan Main Business

Table 137. Mylan Latest Developments

Table 138. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors

Table 139. Orion Corporation Betahistine Product Offered

Table 140. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Orion Corporation Main Business

Table 142. Orion Corporation Latest Developments

List of Figures

Figure 1. Picture of Betahistine

Figure 2. Betahistine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Betahistine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Betahistine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Betahistine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 8mg

Figure 10. Product Picture of 25mg

Figure 11. Product Picture of Others

Figure 12. Global Betahistine Sales Market Share by Type in 2021

Figure 13. Global Betahistine Revenue Market Share by Type (2017-2022)

Figure 14. Betahistine Consumed in Cerebral Thrombosis

Figure 15. Global Betahistine Market: Cerebral Thrombosis (2017-2022) & (K Units)

Figure 16. Betahistine Consumed in Cerebral Embolism

Figure 17. Global Betahistine Market: Cerebral Embolism (2017-2022) & (K Units)

Figure 18. Betahistine Consumed in Others

Figure 19. Global Betahistine Market: Others (2017-2022) & (K Units)

Figure 20. Global Betahistine Sales Market Share by Application (2017-2022)

Figure 21. Global Betahistine Revenue Market Share by Application in 2021

Figure 22. Betahistine Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Betahistine Revenue Market Share by Company in 2021

Figure 24. Global Betahistine Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Betahistine Revenue Market Share by Geographic Region in 2021

Figure 26. Global Betahistine Sales Market Share by Region (2017-2022)

Figure 27. Global Betahistine Revenue Market Share by Country/Region in 2021

Figure 28. Americas Betahistine Sales 2017-2022 (K Units)

Figure 29. Americas Betahistine Revenue 2017-2022 ($ Millions)

Figure 30. APAC Betahistine Sales 2017-2022 (K Units)

Figure 31. APAC Betahistine Revenue 2017-2022 ($ Millions)

Figure 32. Europe Betahistine Sales 2017-2022 (K Units)

Figure 33. Europe Betahistine Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Betahistine Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Betahistine Revenue 2017-2022 ($ Millions)

Figure 36. Americas Betahistine Sales Market Share by Country in 2021

Figure 37. Americas Betahistine Revenue Market Share by Country in 2021

Figure 38. United States Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Betahistine Sales Market Share by Region in 2021

Figure 43. APAC Betahistine Revenue Market Share by Regions in 2021

Figure 44. China Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Betahistine Sales Market Share by Country in 2021

Figure 51. Europe Betahistine Revenue Market Share by Country in 2021

Figure 52. Germany Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Betahistine Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Betahistine Revenue Market Share by Country in 2021

Figure 59. Egypt Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Betahistine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Betahistine in 2021

Figure 65. Manufacturing Process Analysis of Betahistine

Figure 66. Industry Chain Structure of Betahistine

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390